You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 10,780,112


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,780,112 protect, and when does it expire?

Patent 10,780,112 protects PLENVU and is included in one NDA.

This patent has sixty-nine patent family members in thirty-four countries.

Summary for Patent: 10,780,112
Title:Colonoscopy-preparation
Abstract: The invention provides a colon cleansing solution comprising: a) 300 to 2000 mmol per litre ascorbate anion provided by ascorbic acid, one or more salts of ascorbic acid, or a mixture thereof; and b) 10 to 200 g per litre polyethylene glycol. The invention also provides methods and kits associated with, or making use of the solutions. The invention also provides a method of cleansing the colon of a subject comprising: --administering to the subject an effect amount of a first cleansing solution; and then after a time interval --administering to the subject an effective amount of a second cleansing solution, wherein the two cleansing solutions are as described in the specification.
Inventor(s): Halphen; Marc (London, GB), Gruss; Hans-Jurgen (London, GB), Cox; Ian (London, GB), Cockett; Alasdair (London, GB), Stein; Peter (Amsterdam, NL), Ungar; Alex (Wigton, GB)
Assignee: NORGINE BV (Amsterdam, NL)
Application Number:16/788,590
Patent Claim Types:
see list of patent claims
Composition; Formulation; Device;

Drugs Protected by US Patent 10,780,112

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Salix PLENVU ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate FOR SOLUTION;ORAL 209381-001 May 4, 2018 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,780,112

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom1104200.9Mar 11, 2011
United Kingdom1104202.5Mar 11, 2011
United Kingdom1114629.7Aug 23, 2011

International Family Members for US Patent 10,780,112

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3141251 ⤷  Sign Up 122021000018 Germany ⤷  Sign Up
European Patent Office 3141251 ⤷  Sign Up 132021000000044 Italy ⤷  Sign Up
European Patent Office 3141251 ⤷  Sign Up 301099 Netherlands ⤷  Sign Up
European Patent Office 3141251 ⤷  Sign Up C202130017 Spain ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.